DD273381A5 - Verfahren zur herstellung einer spiro-azolonverbindung - Google Patents
Verfahren zur herstellung einer spiro-azolonverbindung Download PDFInfo
- Publication number
- DD273381A5 DD273381A5 DD88319458A DD31945888A DD273381A5 DD 273381 A5 DD273381 A5 DD 273381A5 DD 88319458 A DD88319458 A DD 88319458A DD 31945888 A DD31945888 A DD 31945888A DD 273381 A5 DD273381 A5 DD 273381A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- spiro
- compound
- product
- methyl
- mol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1987/002196 WO1989001775A1 (en) | 1987-09-04 | 1987-09-04 | Azolidinedione derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD273381A5 true DD273381A5 (de) | 1989-11-15 |
Family
ID=22202540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD88319458A DD273381A5 (de) | 1987-09-04 | 1988-09-02 | Verfahren zur herstellung einer spiro-azolonverbindung |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0306251A3 (ko) |
| JP (1) | JPS6471882A (ko) |
| KR (1) | KR900008841B1 (ko) |
| CN (1) | CN1022325C (ko) |
| AU (1) | AU595467B2 (ko) |
| CS (1) | CS273186B2 (ko) |
| DD (1) | DD273381A5 (ko) |
| DK (1) | DK488688A (ko) |
| EG (1) | EG18591A (ko) |
| FI (1) | FI901087A0 (ko) |
| HU (1) | HU204832B (ko) |
| IL (1) | IL87590A (ko) |
| MX (1) | MX12896A (ko) |
| MY (1) | MY103765A (ko) |
| NO (1) | NO901016L (ko) |
| PH (1) | PH24957A (ko) |
| PL (1) | PL156798B1 (ko) |
| PT (1) | PT88407B (ko) |
| WO (1) | WO1989001775A1 (ko) |
| YU (1) | YU46863B (ko) |
| ZA (1) | ZA886507B (ko) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5068333A (en) * | 1990-03-07 | 1991-11-26 | Pfizer Inc. | 6-chloro-3,4-dihydro-pyrano [2,3-b]pyridines having the R configuration |
| DE10210195B4 (de) | 2002-03-07 | 2005-12-15 | Schwarz Pharma Ag | Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz |
| KR101308227B1 (ko) * | 2005-04-21 | 2013-09-13 | 이시하라 산교 가부시끼가이샤 | 니코틴산 유도체 또는 그의 염의 제조 방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1088945A (en) * | 1976-10-18 | 1980-11-04 | Pfizer Limited | Hydantoin derivatives as therapeutic agents |
| US4176185A (en) * | 1979-01-22 | 1979-11-27 | Pfizer Inc. | Spiro-quinolylhydantoins |
| US4226875A (en) * | 1979-04-02 | 1980-10-07 | Pfizer Inc. | Novel spiro-oxazolidinediones |
| FR2455046A1 (fr) * | 1979-04-25 | 1980-11-21 | Science Union & Cie | Nouvelles hydantoines, leur procede de preparation et leur emploi comme medicament |
| US4235911A (en) * | 1979-06-13 | 1980-11-25 | Pfizer Inc. | Hydantoin derivatives |
| US4248882A (en) * | 1980-02-12 | 1981-02-03 | Pfizer Inc. | Treating diabetes-associated complications with hydantoin amines |
| EP0065392B1 (en) * | 1981-05-13 | 1985-02-13 | Imperial Chemical Industries Plc | Pharmaceutical compositions containing spiro succinimide derivatives |
-
1987
- 1987-09-04 WO PCT/US1987/002196 patent/WO1989001775A1/en active Application Filing
- 1987-09-04 MX MX1289688A patent/MX12896A/es unknown
- 1987-09-04 HU HU875809A patent/HU204832B/hu not_active IP Right Cessation
-
1988
- 1988-08-29 MY MYPI88000968A patent/MY103765A/en unknown
- 1988-08-29 IL IL87590A patent/IL87590A/xx unknown
- 1988-08-30 EP EP88307985A patent/EP0306251A3/en not_active Withdrawn
- 1988-09-01 JP JP63219621A patent/JPS6471882A/ja active Granted
- 1988-09-01 ZA ZA886507A patent/ZA886507B/xx unknown
- 1988-09-01 EG EG465/88A patent/EG18591A/xx active
- 1988-09-02 AU AU21841/88A patent/AU595467B2/en not_active Ceased
- 1988-09-02 CS CS591188A patent/CS273186B2/cs not_active IP Right Cessation
- 1988-09-02 DD DD88319458A patent/DD273381A5/de not_active IP Right Cessation
- 1988-09-02 PL PL1988274504A patent/PL156798B1/pl unknown
- 1988-09-02 PT PT88407A patent/PT88407B/pt not_active IP Right Cessation
- 1988-09-02 YU YU167788A patent/YU46863B/sh unknown
- 1988-09-02 PH PH37490A patent/PH24957A/en unknown
- 1988-09-02 DK DK488688A patent/DK488688A/da not_active Application Discontinuation
- 1988-09-03 CN CN88106484A patent/CN1022325C/zh not_active Expired - Fee Related
- 1988-09-03 KR KR1019880011369A patent/KR900008841B1/ko not_active IP Right Cessation
-
1990
- 1990-03-02 NO NO90901016A patent/NO901016L/no unknown
- 1990-03-02 FI FI901087A patent/FI901087A0/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| YU167788A (en) | 1990-06-30 |
| ZA886507B (en) | 1990-04-25 |
| CN1031702A (zh) | 1989-03-15 |
| CN1022325C (zh) | 1993-10-06 |
| IL87590A (en) | 1992-07-15 |
| DK488688D0 (da) | 1988-09-02 |
| JPS6471882A (en) | 1989-03-16 |
| FI901087A0 (fi) | 1990-03-02 |
| NO901016D0 (no) | 1990-03-02 |
| HU204832B (en) | 1992-02-28 |
| EG18591A (en) | 1993-06-30 |
| HUT56106A (en) | 1991-07-29 |
| NO901016L (no) | 1990-05-02 |
| CS591188A2 (en) | 1990-06-13 |
| WO1989001775A1 (en) | 1989-03-09 |
| KR890005112A (ko) | 1989-05-11 |
| JPH0583554B2 (ko) | 1993-11-26 |
| AU595467B2 (en) | 1990-03-29 |
| PL274504A1 (en) | 1989-05-02 |
| DK488688A (da) | 1989-04-07 |
| CS273186B2 (en) | 1991-03-12 |
| YU46863B (sh) | 1994-06-24 |
| AU2184188A (en) | 1989-03-09 |
| PT88407B (pt) | 1992-10-30 |
| EP0306251A2 (en) | 1989-03-08 |
| KR900008841B1 (ko) | 1990-11-30 |
| EP0306251A3 (en) | 1990-08-01 |
| PT88407A (pt) | 1989-07-31 |
| PL156798B1 (pl) | 1992-04-30 |
| MX12896A (es) | 1993-06-01 |
| IL87590A0 (en) | 1989-01-31 |
| PH24957A (en) | 1990-12-26 |
| MY103765A (en) | 1993-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2733868A1 (de) | Neue 1,2,4,5-tetrahydro-3h-2-benzazepin-3-one, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
| DE3614132A1 (de) | 1,3-dihydro-2h-imidazo(4,5-b)chinolin-2-one, verfahren zu deren herstellung und diese verbindungen enthaltende, pharmazeutische mittel | |
| DE19649460A1 (de) | Neue substituierte Pyrazolderivate | |
| DD261154A5 (de) | Verfahren zur herstellung einer hypoglykaemisch wirksamen thiozolidindion-verbindung | |
| EP0291799B1 (de) | Dioxyalkylenaryl-Dihydropyridine Zwischenprodukte zu ihrer Herstellung, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| US4980357A (en) | Azolidinedione derivatives | |
| DE2746244A1 (de) | Spiro-hydantoin-verbindungen und ihre verwendung | |
| EP0258729B1 (de) | Dihydropyridinverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DD213925A5 (de) | Verfahren zur herstellung von acylderivaten von 1,4:3,6-dianhydro-hexiten | |
| DE69018876T2 (de) | Pyridazinon-Derivate. | |
| DE3486020T2 (de) | Spirotricycloaromatische succinimidderivate als aldose-reduktase-inhibitoren. | |
| DE2418344A1 (de) | Derivate von 3-nitrocumarinen enthaltende arzneimittel, neue 3-nitrocumarine und verfahren zu ihrer herstellung | |
| DE3784835T2 (de) | Chinoxalinon-derivate. | |
| EP0155903B1 (de) | Indolophenanthridine, ihre Herstellung und Verwendung | |
| DE2647041C2 (de) | 3-Aminomethylen-6,7-dimethoxy-2- methyl-4-oxo-1,2,3,4-tetrahydro-1-chinolincarbonsäureäthylester | |
| DD273381A5 (de) | Verfahren zur herstellung einer spiro-azolonverbindung | |
| DE4038752A1 (de) | Chromanderivate | |
| EP0001108B1 (de) | Neue 1,4-Dihydropyridazine, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln | |
| DD219482A5 (de) | Verfahren zur herstellung von spiro-3-heteroazolonen | |
| DD219772A5 (de) | Verfahren zur herstellung von spiro-hydantoin-derivaten | |
| EP0235347B1 (de) | Dihydropyridinlactole, Verfahren zur Herstellung und ihre Verwendung in Arzneimitteln | |
| DE3732146A1 (de) | Azachromanderivate | |
| DE3020421A1 (de) | Imidazoazolalkensaeureamide, neue zwischenprodukte zu ihrer herstellung, ihre herstellung und ihre verwendung in arzneimitteln | |
| EP0045521B1 (de) | Pyrazolobenzazepine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| DE2733056C2 (de) | Vincamenin und seine Säureadditionssalze, solche enthaltende Arzneimittel sowie Verfahren zur Herstellung der genannten Verbindungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NPV | Change in the person, the name or the address of the representative (addendum to changes before extension act) | ||
| ENJ | Ceased due to non-payment of renewal fee |